Details
Stereochemistry | ACHIRAL |
Molecular Formula | C4H3FN2O |
Molecular Weight | 114.0778 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
FC1=CNC(=O)N=C1
InChI
InChIKey=HPABFFGQPLJKBP-UHFFFAOYSA-N
InChI=1S/C4H3FN2O/c5-3-1-6-4(8)7-2-3/h1-2H,(H,6,7,8)
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Phase I clinical trial of 5-fluoro-pyrimidinone (5FP), an oral prodrug of 5-fluorouracil (5FU). | 2002 Feb |
|
Guest-induced modification of a magnetically active ultramicroporous, gismondine-like, copper(II) coordination network. | 2008 Mar 26 |
|
Capecitabine from X-ray powder synchrotron data. | 2009 May 20 |
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB197488
Created by
admin on Fri Dec 15 15:42:46 GMT 2023 , Edited by admin on Fri Dec 15 15:42:46 GMT 2023
|
PRIMARY | |||
|
2022-78-8
Created by
admin on Fri Dec 15 15:42:46 GMT 2023 , Edited by admin on Fri Dec 15 15:42:46 GMT 2023
|
PRIMARY | |||
|
529069
Created by
admin on Fri Dec 15 15:42:46 GMT 2023 , Edited by admin on Fri Dec 15 15:42:46 GMT 2023
|
PRIMARY | |||
|
100000183178
Created by
admin on Fri Dec 15 15:42:46 GMT 2023 , Edited by admin on Fri Dec 15 15:42:46 GMT 2023
|
PRIMARY | |||
|
101498
Created by
admin on Fri Dec 15 15:42:46 GMT 2023 , Edited by admin on Fri Dec 15 15:42:46 GMT 2023
|
PRIMARY | |||
|
1VXI7T1BI5
Created by
admin on Fri Dec 15 15:42:46 GMT 2023 , Edited by admin on Fri Dec 15 15:42:46 GMT 2023
|
PRIMARY | |||
|
DTXSID90174067
Created by
admin on Fri Dec 15 15:42:46 GMT 2023 , Edited by admin on Fri Dec 15 15:42:46 GMT 2023
|
PRIMARY |
ACTIVE MOIETY